A Phase I/IIa Study of UV1 Vaccination in Patients With Non Small Cell Lung Cancer.
NCT01789099
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
18
Enrollment
INDUSTRY
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
BIOLOGICAL:
UV1 synthetic peptide vaccine and GM-CSF
Sponsor
Ultimovacs ASA
Collaborators
[object Object]